US OptionsDetailed Quotes

BTCY241220P5000

Watchlist
  • 0.00
  • 0.000.00%
15min DelayTrading Nov 26 09:30 ET
0.00High0.00Low
Intraday
  • 5D
  • Daily

No Data

Comments

    $Biotricity (BTCY.US)$
    Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program
    Biotricity (Nasdaq: BTCY) has launched a new cardiac monitoring pilot program with a prominent hospital group, covering 60 sites across multiple states. The company's three-channel connected solution offers superior diagnostics, reduced patient risk, and improved workflow efficiency, resulting in better clinical outcomes and lower healthcare costs.
    This program positions Biotricity to acceler...
    1
    $Biotricity (BTCY.US)$ • Biotricity's fiscal year 2024 revenue rose to $12.06 million, a 25% increase, with Q4 revenue up 15.9% to $3.2 million.
    • Gross profit for the quarter was $2.3 million, a 48% year-over-year increase, with a gross margin of 71.5%.
    • Operating expenses decreased by 17%, and the company is aiming for EBITDA neutrality and profitability soon.
    • Strategic initiatives included the launch of Biocore Pro and HeartSecure, partnerships with industry leaders, and ex...
    $Biotricity (BTCY.US)$ Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available
    Accesswire· 1 min ago
    Democratizing cardiac health with convenient, rapid, and reliable results
    $Biotricity (BTCY.US)$
    Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market
    Biotricity, a leader in Technology-as-a-Service (TaaS) for healthcare, has launched HeartSecure, a direct-to-consumer heart health screening service.
    Heart disease is a major global health issue, with cardiovascular disease causing one death every 1.5...
    $Biotricity (BTCY.US)$ Not even a great improvement YoY in earnings can get any volume! Hehehe! Now thats some pathetic interest
Read more